Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Goddard

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Psychiatric Services (Washington, D.C.)|May 17, 2016
Trends in Use and Cost of Second-Generation Antipsychotics Among Children and Teens in Indiana Medicaid, 2004-2012Andrew W Goddard, Katherine Schwartz, Kristin Hendrix, et al.
Psychiatric Services (Washington, D.C.)|September 3, 2011
Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorderKaren L Rascati, Kristin M Richards, Carol A Ott, et al.
Psychiatry Research|May 20, 1999
Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorderA W Goddard, S W Woods, R Money, et al.
Archives of General Psychiatry|June 29, 2001
Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopyA W Goddard, G F Mason, A Almai, et al.
Biological Psychiatry|July 15, 1995
Effects of tryptophan depletion on responses to yohimbine in healthy human subjectsA W Goddard, D S Charney, M Germine, et al.
Nature Medicine|December 29, 2009
A key role for orexin in panic anxietyPhilip L Johnson, William Truitt, Stephanie D Fitz, et al.
Comprehensive Psychiatry|November 26, 1998
Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorderC M Grilo, R Money, D H Barlow, et al.
Biological Psychiatry|February 9, 2000
SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorderJ D Bremner, R B Innis, T White, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZMJ P Seibyl, S W Woods, S S Zoghbi, et al.
The Journal of Clinical Psychiatry|July 12, 2013
Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorderEric A Storch, Andrew W Goddard, Jon E Grant, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Psychiatric Services (Washington, D.C.)|May 17, 2016
Trends in Use and Cost of Second-Generation Antipsychotics Among Children and Teens in Indiana Medicaid, 2004-2012Andrew W Goddard, Katherine Schwartz, Kristin Hendrix, et al.
Psychiatric Services (Washington, D.C.)|September 3, 2011
Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorderKaren L Rascati, Kristin M Richards, Carol A Ott, et al.
Psychiatry Research|May 20, 1999
Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorderA W Goddard, S W Woods, R Money, et al.
Archives of General Psychiatry|June 29, 2001
Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopyA W Goddard, G F Mason, A Almai, et al.
Biological Psychiatry|July 15, 1995
Effects of tryptophan depletion on responses to yohimbine in healthy human subjectsA W Goddard, D S Charney, M Germine, et al.
Nature Medicine|December 29, 2009
A key role for orexin in panic anxietyPhilip L Johnson, William Truitt, Stephanie D Fitz, et al.
Comprehensive Psychiatry|November 26, 1998
Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorderC M Grilo, R Money, D H Barlow, et al.
Biological Psychiatry|February 9, 2000
SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorderJ D Bremner, R B Innis, T White, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZMJ P Seibyl, S W Woods, S S Zoghbi, et al.
The Journal of Clinical Psychiatry|July 12, 2013
Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorderEric A Storch, Andrew W Goddard, Jon E Grant, et al.
Pageof 5